| 英文别名 |
2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid;N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid;N-(3-Trifluoromethylphenyl)anthranilic acid;Flufenamic Acid;2-[3-(trifluoromethyl)anilino]benzoic acid;2-{[3-(Trifluoromethyl)phenyl]amino}benzoic acid;3'-TRIFLUOROMETHYLDIPHENYLAMINE-2-CARBOXYLIC ACID;FLUFENAMIC ACD;2-(3-Trifluoromethylanilino)benzoic Acid;2-[(3-Trifluoromethylphenyl)amino]benzoic Acid;Fluphenamic acid;Nichisedan;Achless;Arlef;Tecramine;Paraflu;Lanceat;Flufacid;Plostene;Fullsafe;Parlef;Surika;Parlif;Flufenaminsaeure;Reumajust A;Acido flufenamico;Ristogen;Sastridex;Meralen;Ansatin;ANT-1;Acide flufenamique;Acidum flufenamicum;TVX 916;INF 1837;CI;Tox21_110452_1;HMS1921B21;BRD-K44067360-001-06-3;KBio2_007403;Arlef (TN);SCHEMBL17497;KS-1143;HMS1791B21;N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid;CCG-40167;NCGC00016490-07;CBDivE_012649;NCGC00016490-06;IDI1_000581;n-(a,a,a-trifluoro-m-tolyl)anthranilic acid;Bio1_000042;Z56797275;NSC219007;KBioSS_002268;NCGC00255175-01;CN-27554;Pharmakon1600-01501015;BRN 1996069;F0909-0007;HMS2095J07;KBio3_000077;NCGC00016490-02;N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid;FLF;UNM000001246003;NCGC00023200-07;Fluore-200;Spectrum5_000686;Tox21_302111;EN300-16858;BCBcMAP01_000039;NCGC00016490-05;3-14-00-00905 (Beilstein Handbook Reference);Prestwick_220;NCGC00016490-03;KBio2_006873;NSC 219007;Bio1_001020;SR-01000000241;Spectrum3_001273;cMAP_000004;Acido flufenamico [INN-Spanish];FFA;flufenamic-acid;KBio2_004835;HMS3652F06;CN-27,554;FLUFENAMIC ACID [JAN];SBI-0051633.P002;EINECS 208-494-1;AB00052198_15;HY-B1221;Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-;Spectrum_001257;FLUFENAMIC ACID [MI];NS00000475;KBio1_000581;HMS1568J07;D97458;N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid;CI-440;KBio3_002747;Q416341;CHEBI:42638;N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid;HMS3885P15;BSPBio_001319;NSC757823;2-((3-Trifluromethyl)phenyl)aminobenzoic acid;KBio2_000039;CAS-530-78-9;NCGC00023200-03;2-[(3-Trifluromethyl)phenyl]aminobenzoic acid;Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-;Flufenamicacid;Acido flufenamico [Italian];FLUFENAMIC ACID [WHO-DD];HMS2089E07;GTPL2447;DB02266;NCGC00016490-09;SW196528-3;SPBio_002106;2-(3-(trifluoromethyl)phenylamino)benzoic acid;HMS2092B09;FT-0603454;KBio2_002607;Bio2_000519;NCGC00016490-01;NCGC00016490-10;NCGC00023200-05;FLUFENAMIC ACID [USAN];Spectrum4_000102;MLS001148610;s4268;HMS2232G24;Prestwick1_000203;KBio3_000078;T2354;N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid;W-105772;GLXC-27023;Flufenamic acid, analytical standard, for drug analysis;Prestwick0_000203;CI 440;Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-;NSC82699;WLN: QVR BMR CXFFF;SPBio_000898;KBio2_004305;Acide flufenamique [INN-French];2-[3-(Trifluoromethyl)anilino]benzoic acid #;530-78-9;60GCX7Y6BH;BPBio1_000205;Flufenamic acid (JAN/USAN/INN... |